This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Wedbush analyst David Nierengarten downgraded the rating for Ikena Oncology, Inc. IKNA from Outperform to Neutral, while slashing the price target from $8 to $2. Ikena Oncology shares closed at $1.33 on Tuesday. See how other analysts view this stock.
• Wells Fargo analyst Finian O’Shea downgraded Goldman Sachs BDC, Inc. GSBD from Equal-Weight to Underweight and cut the price target from $15 to $14. Goldman Sachs BDC shares fell 0.1% to settle at $15.18 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Benjamin Gerlinger downgraded the rating for Bank OZK OZK from Buy to Sell, while cutting the price target from $57 to $37. Bank OZK shares fell 0.7% to settle at $46.19 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
• Jefferies analyst Sheila Kahyaoglu downgraded American Airlines Group Inc. AAL from Buy to Hold and slashed the price target from $17 to $12. American Airlines shares fell 2.9% to close at $13.44 on Tuesday. See how other analysts view this stock.
• Baird analyst David Manthey downgraded the rating for WESCO International, Inc. WCC from Outperform to Neutral, while lowering the price target from $200 to $195. WESCO shares fell 3% to settle at $185.52 on Tuesday. See how other analysts view this stock.

Check This Out: Top 3 Tech Stocks That May Implode In May